All Stories

  1. Nano-in-Micro GelMA depots assist electro-thermal-immuno orchestral treatment for solid triple negative breast tumor
  2. Harnessing nature's blueprint: Unlocking the potential of subcellular structure membrane-coated nanosystems for precision medicine
  3. High drug-loaded supramolecular microgels enabled by controlled in-droplet self-assembly for adaptive treatment of inflammatory arthritis
  4. A Review of Current Computational Tools for Peptide–Protein Docking
  5. Combined M1 macrophage inhibition and thermotherapy for controlled fibroplasia and accelerated wound repair via an oxygenating ROS-responsive hydrogel
  6. Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design
  7. Nanoparticle‐Mediated Delivery of Adenosine 5′‐Monophosphate Enhances 5‐Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure
  8. Poly(lactic‐co‐glycolic acid) Nanoparticles for IL‐12 Self‐Amplifying RNA Delivery in Glioblastoma Models
  9. Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery
  10. Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance
  11. A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on
  12. Design and in vitro validation of Brome mosaic –virus-like particles for gene delivery and immunomodulation of melanoma
  13. Quantum sensing of free radicals in macrophages reveals early autophagy-lysosome regulation in an atherosclerosis cell model
  14. Nanoencapsulated flavonoids for enhanced modulation of the microbiota-gut-brain axis and neurodegenerative add-on therapy
  15. Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses
  16. Outside Front Cover
  17. Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering
  18. Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
  19. Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials
  20. Organ-on-Chip Platforms for Nanoparticle Toxicity and Efficacy Assessment: Advancing Beyond Traditional In Vitro and In Vivo Models
  21. Metal-organic frameworks in sample preparation for clinical applications – A review
  22. Artificial cells and biomimicry cells: A rising star in the fight against cancer
  23. Probing Early Particle‐Cell Membrane Interactions via Single‐Cell and Single‐Particle Interaction Analysis
  24. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens
  25. Integrated Microfluidic Chip for Neutrophil Extracellular Vesicle Analysis and Gastric Cancer Diagnosis
  26. Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
  27. Biological Augmentation Using Electrospun Constructs with Dual Growth Factor Release for Rotator Cuff Repair
  28. Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
  29. H2O2‐Generating Advanced Nanomaterials for Cancer Treatment
  30. Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming
  31. Local glycolysis-modulating hydrogel microspheres for a combined anti-tumor and anti-metastasis strategy through metabolic trapping strategy
  32. Reactive oxygen species switcher via MnO2-coated Prussian blue loaded hyaluronic acid methacrylate hydrogel microspheres for local anti-tumor treatment
  33. Broad-spectrum downregulation of inflammatory cytokines by polydopamine nanoparticles to protect the injured spinal cord
  34. Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis
  35. Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method
  36. Development of Amniotic Epithelial Stem Cells Secretome-Loaded In Situ Inverse Electron Demand Diels–Alder-Cross-Linked Hydrogel as a Potential Immunomodulatory Therapeutical Tool
  37. Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
  38. Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells
  39. Hijacking plant skeletons for biomedical applications: from regenerative medicine and drug delivery to biosensing
  40. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)
  41. Tailored polysaccharide entrapping metal-organic framework for RNAi therapeutics and diagnostics in atherosclerosis
  42. Preface
  43. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders
  44. A Near-Infrared Light Absorbable Hydrogel with Antibacterial Effect for Mild Photothermal Regeneration of Infected Wounds
  45. Polymeric Microspheres with High Mass Fraction of Therapeutics Enabled by the Manipulation of Kinetics Factor During Emulsion Droplet Solidification
  46. A study of the oral bioavailability and biodistribution increase of Nanoencapsulation-driven Delivering radiolabeled anthocyanins
  47. Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells
  48. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  49. Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo
  50. Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
  51. Electrochemical detection of atrial natriuretic peptide-coated nanocarriers based on a molecularly imprinted polymer receptor thin film
  52. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo
  53. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
  54. A translational framework to DELIVER nanomedicines to the clinic
  55. Breaking barriers: The potential of nanosystems in antituberculosis therapy
  56. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management
  57. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  58. Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction
  59. Unlocking the potential of nanomedicine: advances in precision targeting strategies
  60. Front Cover: Nano Select 7–8 / 2024
  61. Self‐Nanoformulating Poly(2‐oxazoline) and Poly(2‐oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  62. Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes
  63. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
  64. Special Issue on Advances in Porous Materials
  65. Comparative optimization of polysaccharide-based nanoformulations for cardiac RNAi therapy
  66. Implantable Patch of Oxidized Nanofibrillated Cellulose and Lysozyme Amyloid Nanofibrils for the Regeneration of Infarcted Myocardium Tissue and Local Delivery of RNA‐Loaded Nanoparticles
  67. Lipid nanoparticles-based RNA therapies for breast cancer treatment
  68. Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  69. Curcuma Longa: Nutraceutical Use and Association With Nanotechnology
  70. Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
  71. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  72. Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy
  73. In Situ Biofabrication of Microbial Cellulose Capsules Carrying Cubosomes: Toward Colon Targeted Multidrug Delivery
  74. Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
  75. Physicochemical characterization of a lycopene‐loaded mesoporous silica nanoparticle formulation
  76. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
  77. Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry
  78. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs
  79. Engineering and Targeting Neutrophils for Cancer Therapy
  80. Porous Silicon Nanoparticles Conjugated Magnetite‐Chitosan Graphene Oxide Nanoparticles for Effective Removal of Complex Pollutants
  81. Inside Back Cover
  82. Diatom-guided bone healing via a hybrid natural scaffold
  83. Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide
  84. Quantum Sensing of Free Radical Generation in Mitochondria of Single Heart Muscle Cells during Hypoxia and Reoxygenation
  85. Porous Si-Based Nanosystems for Immunotherapy Applications
  86. Noninvasive Novel Transdermal Drug Delivery System for Deep Drug Permeability
  87. Cell-based in vitro models for buccal permeability studies
  88. Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
  89. Diversity-oriented combinatory formulation screen for cardiac RNAi therapeutics with polysaccharide framework
  90. Polyethylene Glycol‐Stabilized Gold Nanostars‐Loaded Microneedles for Photothermal Therapy of Melanoma
  91. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy (Adv. Funct. Mater. 46/2023)
  92. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  93. Advanced porous materials for antimicrobial treatment
  94. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model
  95. Mycophenolic Acid-loaded Naïve Macrophage-derived Extracellular Vesicles Rescue Cardiac Myoblast after Inflammatory Injury
  96. Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
  97. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy
  98. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond
  99. Development of a time-dependent oral colon delivery system of anaerobic Odoribacter splanchnicus for bacteriotherapy
  100. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study (Adv. Funct. Mater. 34/2023)
  101. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy
  102. Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
  103. Development of fast dissolving polymer-based microneedles for delivery of an antigenic melanoma cell membrane
  104. Double‐Layered Polyvinylpyrrolidone–Poly(methyl vinyl ether‐alt‐maleic acid)‐Based Microneedles to Deliver Meloxicam: An In Vitro, In Vivo, and Short‐Term Stability Evaluation Study
  105. In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers
  106. Fabricated technology of biomedical micro-nano hydrogel
  107. Multifunctional nanostructures: Intelligent design to overcome biological barriers
  108. Development of siRNA and Budesonide Dual‐Loaded Hybrid Lipid–Polymer Nanoparticles by Microfluidics Technology as a Platform for Dual Drug Delivery to Macrophages: An In Vitro Mechanistic Study
  109. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study
  110. Injectable Nanocomposite Hydrogels of Gelatin-Hyaluronic Acid Reinforced with Hybrid Lysozyme Nanofibrils-Gold Nanoparticles for the Regeneration of Damaged Myocardium
  111. In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes
  112. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
  113. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues
  114. Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
  115. A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation
  116. Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications
  117. Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications
  118. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
  119. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications
  120. Introduction to the RSC Advances themed collection on Nanomaterials in drug delivery
  121. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)
  122. Microfluidics as a Tool for the Synthesis of Advanced Drug Delivery Systems
  123. Fabrication of hydrogel microspheres via microfluidics using inverse electron demand Diels–Alder click chemistry-based tetrazine-norbornene for drug delivery and cell encapsulation applications
  124. Smart Nanoparticle‐based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
  125. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells
  126. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (Adv. Mater. 42/2022)
  127. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect
  128. Development of Surface Chemical Strategies for Synthesizing Redox‐Responsive Diatomite Nanoparticles as a Green Platform for On‐Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent
  129. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform (Adv. Funct. Mater. 36/2022)
  130. Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
  131. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform
  132. Microfluidics fabrication of micrometer‐sized hydrogels with precisely controlled geometries for biomedical applications
  133. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
  134. Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
  135. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins
  136. Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection
  137. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform
  138. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases
  139. Artificial Intelligence Deep Exploration of Influential Parameters on Physicochemical Properties of Curcumin‐Loaded Electrospun Nanofibers
  140. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury
  141. Functional biomaterials
  142. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium
  143. Biomimetic platelet membrane-coated nanoparticles for targeted therapy
  144. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
  145. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy
  146. Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant and Bioresorbability Properties for Myocardial Regeneration Applications
  147. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
  148. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
  149. Scaffold Vaccines for Generating Robust and Tunable Antibody Responses
  150. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
  151. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
  152. Emerging Theranostic Nanomaterials in Diabetes and Its Complications
  153. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  154. Inhibiting Phase Transfer of Protein Nanoparticles by Surface Camouflage–A Versatile and Efficient Protein Encapsulation Strategy
  155. In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
  156. Prospective Cancer Therapies Using Stimuli‐Responsive DNA Nanostructures
  157. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy (Adv. Mater. 40/2021)
  158. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
  159. Programmable immune activating electrospun fibers for skin regeneration
  160. Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
  161. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
  162. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy
  163. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
  164. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by 1H NMR
  165. Engineering of 2D Materials To Trap And Kill SARS-CoV-2: A New Insight From Multi-Microsecond Atomistic Simulations
  166. Light‐Controlled Nanosystems: Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression (Adv. Funct. Mater. 27/2021)
  167. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
  168. Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
  169. Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
  170. An organic-inorganic hybrid scaffold with honeycomb-like structures enabled by one-step self-assembly-driven electrospinning
  171. Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression
  172. A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
  173. Mitochondria‐Targeted Bovine Serum Albumin@Copper Sulfide Nanocomposites Conjugated with Rhodamine‐110 Dye for an Enhanced Efficacy of Cancer Photothermal Therapy
  174. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
  175. DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy
  176. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
  177. Synthesis and therapeutic potential of stimuli-responsive metal-organic frameworks
  178. One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases
  179. Engineered Extracellular Vesicles for Cancer Therapy
  180. Development of vaccine formulations: past, present, and future
  181. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
  182. Microneedles for painless transdermal immunotherapeutic applications
  183. Anti‐Bacterial Hydrogels: A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration (Adv. Healthcare Mater. 3/2021)
  184. Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles
  185. Correction: Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  186. Front cover
  187. Advanced Nanosystems for Clinical Translation
  188. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics
  189. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  190. Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds
  191. Conventional Nanosized Drug Delivery Systems for Cancer Applications
  192. Front Matter
  193. Introduction to lignocellulosic materials
  194. Requirements and properties of biomaterials for biomedical applications
  195. Bio-Nanomedicine for Cancer Therapy
  196. Porous Silicon for Biomedical Applications
  197. Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications
  198. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
  199. Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
  200. Recent progress in the design of DNA vaccines against tuberculosis
  201. Cell–Nanoparticle Interactions: Toxicity and Safety Issues
  202. A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration
  203. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease
  204. Requirements for Animal Experiments: Problems and Challenges
  205. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines
  206. 3D scaffolding of fast photocurable polyurethane for soft tissue engineering by stereolithography: Influence of materials and geometry on growth of fibroblast cells
  207. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
  208. Cell Membrane Wrapping: Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions (Adv. Healthcare Mater. 17/2020)
  209. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique
  210. Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
  211. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
  212. Multifunctional 3D‐Printed Patches for Long‐Term Drug Release Therapies after Myocardial Infarction
  213. Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition
  214. Intracellular Delivery of Budesonide and Polydopamine Co‐Loaded in Endosomolytic Poly(butyl methacrylate‐ co ‐methacrylic acid) Grafted Acetalated Dextran for Macrophage Phenotype Switch from M1 to M2
  215. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization
  216. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
  217. Microvascular Scaffolds: A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds (Adv. Sci. 9/2020)
  218. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
  219. Polyoxometalate Composites in Cancer Therapy and Diagnostics
  220. The solid progress of nanomedicine
  221. A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds
  222. Microfluidics: Microfluidics for Production of Particles: Mechanism, Methodology, and Applications (Small 9/2020)
  223. Gold–silver nanoshells promote wound healing from drug-resistant bacteria infection and enable monitoring via surface-enhanced Raman scattering imaging
  224. Recent trends on the development of systems for cancer diagnosis and treatment by microfluidic technology
  225. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
  226. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
  227. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
  228. Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
  229. Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications
  230. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency
  231. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
  232. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
  233. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties
  234. Microfibers synthesized by wet-spinning of chitin nanomaterials: mechanical, structural and cell proliferation properties
  235. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path
  236. Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells
  237. Novel RET agonist for the treatment of experimental neuropathies
  238. Oral drug delivery: Overview
  239. Spray-drying for the formulation of oral drug delivery systems
  240. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
  241. Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis
  242. Superfast and controllable microfluidic inking of anti-inflammatory melanin-like nanoparticles inspired by cephalopods
  243. Gene‐Hydrogel Microenvironments: Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus (Adv. Sci. 1/2020)
  244. Osteogenic Hydrogels: Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration (Adv. Healthcare Mater. 1/2020)
  245. Cover Image
  246. Nanotechnology for Oral Drug Delivery
  247. Nanomedicine Therapies
  248. Handbook of In Vivo Chemistry in Mice
  249. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles
  250. Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration
  251. Artificially cloaked viral nanovaccine for cancer immunotherapy
  252. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
  253. Antitumor Therapeutics: A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (Adv. Funct. Mater. 51/2019)
  254. Functionalized Bacterial Cellulose Microparticles for Drug Delivery in Biomedical Applications
  255. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting
  256. Microfluidics for Production of Particles: Mechanism, Methodology, and Applications
  257. Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus
  258. A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics
  259. Latest Advances on Bacterial Cellulose‐Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
  260. Landing a lethal blow on bacterial infections: an emerging advance of nanodots for wound healing acceleration
  261. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  262. Antimicrobial Colloidal Silver–Lignin Particles via Ion and Solvent Exchange
  263. Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs
  264. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  265. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  266. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
  267. On the issue of transparency and reproducibility in nanomedicine
  268. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  269. Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
  270. Microfluidics: Nuts and Bolts: Microfluidics for the Production of Biomaterials (Adv. Mater. Technol. 6/2019)
  271. Acetylated Nanocellulose for Single-Component Bioinks and Cell Proliferation on 3D-Printed Scaffolds
  272. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
  273. Preparation and Characterization of Dentin Phosphophoryn‐Derived Peptide‐Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake
  274. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
  275. Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles
  276. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes
  277. Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression
  278. Correction to “Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles”
  279. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid
  280. Self‐Healing: Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration (Adv. Sci. 3/2019)
  281. Metal-Based Stents: Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases (Adv. Mater. 8/2019)
  282. Nuts and Bolts: Microfluidics for the Production of Biomaterials
  283. Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds
  284. Outer–inner dual reinforced micro/nano hierarchical scaffolds for promoting osteogenesis
  285. Advanced Nanovaccines for Immunotherapy Applications: From Concept to Animal Tests
  286. Close-loop dynamic nanohybrids on collagen-ark with in situ gelling transformation capability for biomimetic stage-specific diabetic wound healing
  287. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
  288. Photosensitive materials for constructing on-demanded drug-release systems
  289. Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles
  290. Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases
  291. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides
  292. Euryale Ferox Seed-Inspired Superlubricated Nanoparticles for Treatment of Osteoarthritis
  293. Adjustable hardness of hydrogel for promoting vascularization and maintaining stemness of stem cells in skin flap regeneration
  294. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
  295. Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells
  296. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy
  297. Cell‐Nanoparticle Interactions at (Sub)–Nanometer Resolution Analyzed by Electron Microscopy and Correlative Coherent Anti‐Stokes Raman Scattering
  298. Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  299. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
  300. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
  301. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence
  302. GDNF mimetics delivery by porous silicon nanoparticles for improved Parkinson’s disease management
  303. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications
  304. Light-Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
  305. Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions
  306. Materials Science in Finland
  307. Production of pure drug nanocrystals and nano co-crystals by confinement methods
  308. Materials Science in Finland: (Adv. Mater. 24/2018)
  309. Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin
  310. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review
  311. Sequential Antifouling Surface for Efficient Modulation of the Nanoparticle-Cell Interactions in Protein-Rich Environments
  312. Bioengineered Porous Silicon Nanoparticles@Macrophages Cell Membrane as Composite Platforms for Rheumatoid Arthritis
  313. Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol–Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications
  314. Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
  315. Neuroprotection: Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity (Adv. Mater. 14/2018)
  316. Immunostimulation and Immunosuppression: Nanotechnology on the Brink
  317. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
  318. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
  319. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems
  320. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
  321. Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell
  322. Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity
  323. Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates
  324. Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
  325. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration
  326. Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery
  327. Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
  328. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
  329. 3D printing: prospects and challenges
  330. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs
  331. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
  332. Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
  333. Manipulating Superparamagnetic Microparticles with an Electromagnetic Needle
  334. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics
  335. Fabrication of Calcium Phosphate-Based Nanocomposites Incorporating DNA Origami, Gold Nanorods, and Anticancer Drugs for Biomedical Applications
  336. Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
  337. Non-invasive strategies for targeting the posterior segment of eye
  338. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
  339. Protein Coating of DNA Nanostructures for Enhanced Stability and Immunocompatibility
  340. Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling
  341. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co -maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery
  342. Photoluminescent Hybrids of Cellulose Nanocrystals and Carbon Quantum Dots as Cytocompatible Probes for in Vitro Bioimaging
  343. Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
  344. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
  345. Surface modification of acetaminophen particles by atomic layer deposition
  346. The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
  347. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
  348. Insights into Caco-2 cell culture structure using coherent anti-Stokes Raman scattering (CARS) microscopy
  349. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
  350. Microfluidic Encapsulation of Prickly Zinc-Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy
  351. Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy
  352. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
  353. Nanoreactors: Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions (Adv. Mater. 11/2017)
  354. Drug Delivery: A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals (Adv. Funct. Mater. 9/2017)
  355. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
  356. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
  357. Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)
  358. Fabrication, characterization and evaluation of bacterial cellulose-based capsule shells for oral drug delivery
  359. Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions
  360. A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals
  361. Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
  362. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017)
  363. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy
  364. Microfluidic-assisted fabrication of carriers for controlled drug delivery
  365. Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication
  366. Springer Handbook of Nanotechnology
  367. Nano-Particles for Biomedical Applications
  368. Inside Cover Image, Volume 9, Issue 1
  369. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
  370. Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
  371. Drug Delivery: Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy (Adv. Mater. 46/2016)
  372. Microparticles to enhance delivery of drugs and growth factors into wound sites
  373. Active diffusion of nanoparticles of maternal origin within the embryonic brain
  374. Advances in biomedical and pharmaceutical applications of functional bacterial cellulose-based nanocomposites
  375. Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy
  376. Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods
  377. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
  378. Microfluidics as a cutting-edge technique for drug delivery applications
  379. Targeted Cancer Therapy: pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin (Adv. Healthcare Mater. 15/2016)
  380. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
  381. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models
  382. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
  383. Silica-Based Nanovectors: From Mother Nature to Biomedical Applications
  384. Applications of bacterial cellulose in food, cosmetics and drug delivery
  385. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin
  386. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
  387. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
  388. A comprehensive review of the neonatal Fc receptor and its application in drug delivery
  389. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury
  390. Neovascularization: Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound (Adv. Healthcare Mater. 8/2016)
  391. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound
  392. Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
  393. Mesoporous Biomaterials: a Lexicon and Structured Bibliography of Reviews
  394. Chemotherapy with Porous Silicon
  395. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
  396. Corrigendum to “Polymer-based nanoparticles for oral insulin delivery: Revisited approaches”,[Biotechnol Adv. 2015 Nov 1;33 (6 Pt 3):1342–54]
  397. Opinion Paper: Microfluidics Technique to Revolutionize the Drug Delivery Field: Current Developments and Applications
  398. Copolymers: Drug Delivery
  399. Controlled Shape and Nucleation Switching of Interfacially Polymerizable Nanoassemblies by Methyl Substitution
  400. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
  401. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system
  402. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
  403. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
  404. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy
  405. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions
  406. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
  407. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery
  408. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation
  409. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
  410. Diatomite nanoparticles as potential drug delivery systems
  411. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
  412. Microfluidics: A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties (Adv. Mater. 14/2015)
  413. Multifunctional porous silicon nanoparticles for cancer theranostics
  414. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
  415. Drug Delivery: On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications (Adv. Funct. Mater. 10/2015)
  416. A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties
  417. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
  418. 3.5 Current Trends and Developments for Nanotechnology in Cancer
  419. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications
  420. Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption
  421. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis
  422. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery
  423. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy
  424. Solid state transformations in consequence of electrospraying – A novel polymorphic form of piroxicam
  425. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
  426. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
  427. Revolutionary impact of nanovaccines on immunotherapy
  428. Coherent anti-Stokes Raman scattering microscopy driving the future of loaded mesoporous silica imaging
  429. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications
  430. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
  431. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
  432. Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
  433. Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
  434. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart
  435. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery
  436. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
  437. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
  438. In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging
  439. Gene-based therapy for Type 1 diabetes mellitus: viral and nonviral vectors
  440. Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
  441. Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
  442. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
  443. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
  444. Confinement Effects on Drugs in Thermally Hydrocarbonized Porous Silicon
  445. Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
  446. Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
  447. Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
  448. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
  449. Biocompatibility of porous silicon for biomedical applications
  450. Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
  451. Preface
  452. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
  453. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
  454. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery
  455. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
  456. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
  457. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
  458. Drug delivery with nanostructured porous silicon nanoparticles
  459. Nanostructured Silicon-Based Materials as a Drug Delivery System for Water-Insoluble Drugs
  460. Metabolism of the Antituberculosis Drug Ethionamide
  461. Porous Silicon Nanoparticles
  462. Evaluation of the Physicochemical and Biopharmaceutical Properties of Fluoro-Indomethacin
  463. Editorial (Hot Topic: Non-Animal Models Used in Drug Discovery: Drug Absorption and Metabolism)
  464. Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication
  465. Encyclopedia of Metalloproteins
  466. Nanostructured Porous Silicon-Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
  467. Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
  468. A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
  469. Nanostructured porous Si-based nanoparticles for targeted drug delivery
  470. Porous-based biomaterials for tissue engineering and drug delivery applications
  471. Amine Modification of Thermally Carbonized Porous Silicon with Silane Coupling Chemistry
  472. Toxicological Profile of Therapeutic Nanodelivery Systems
  473. Nanostructured porous silicon materials: potential candidates for improving drug delivery
  474. Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
  475. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
  476. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
  477. Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution
  478. Nanoparticulate targeted drug delivery using peptides and proteins
  479. Cellular interactions of surface modified nanoporous silicon particles
  480. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles
  481. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles
  482. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
  483. Editorial [Hot Topic: Innovative Technologies for Drug Delivery Applications: From Biopolymers and Nanocapsules to Inorganic Materials (Guest Editor: Helder A. Santos)]
  484. Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
  485. 4th BBBB International Conference on Pharmaceutical Sciences
  486. Poster Presentation
  487. Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
  488. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
  489. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  490. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  491. Mesoporous materials as controlled drug delivery formulations
  492. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
  493. Long time effect on the stability of silver nanoparticles in aqueous medium: Effect of the synthesis and storage conditions
  494. Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
  495. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
  496. Electrochemical Properties of Phospholipid Monolayers at Liquid–Liquid Interfaces
  497. Biocompatibility of mesoporous silicon microparticles
  498. Drug dissolution studies on mesoporous silicon particles—A theoretical approach
  499. Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
  500. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy
  501. Adsorption–Penetration Studies of Glucose Oxidase into Phospholipid Monolayers at the 1,2-Dichloroethane/Water Interface
  502. Cover Picture: Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface (ChemPhysChem 6/2007)
  503. Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface
  504. Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of the saturated alkyl chain
  505. Preparation of nanostructures composed of dextran sulfate/ruthenium nanoparticles and their interaction with phospholipid monolayers at a liquid–liquid interface
  506. Electrochemical Study of Interfacial Composite Nanostructures:  Polyelectrolyte/Gold Nanoparticle Multilayers Assembled on Phospholipid/Dextran Sulfate Monolayers at a Liquid−Liquid Interface
  507. Interfacial Interaction between Dextran Sulfate and Lipid Monolayers:  An Electrochemical Study†
  508. CHAPTER 9. Diatoms: A Natural Source of Nanostructured Silica for Drug Delivery